GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Soleno Therapeutics Inc (FRA:6XC) » Definitions » Net Investment Income

Soleno Therapeutics (FRA:6XC) Net Investment Income


View and export this data going back to 2019. Start your Free Trial

What is Soleno Therapeutics Net Investment Income?

Net Investment Income only applies to insurance companies.


Soleno Therapeutics Business Description

Traded in Other Exchanges
Address
100 Marine Parkway, Suite 400, Redwood City, CA, USA, 94065
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.